Palatin Technologies (NYSEAMERICAN:PTN – Get Free Report) released its earnings results on Tuesday. The biopharmaceutical company reported ($0.51) earnings per share (EPS) for the quarter, reports.
Palatin Technologies Trading Up 1.0 %
NYSEAMERICAN PTN opened at $0.83 on Friday. Palatin Technologies has a twelve month low of $0.68 and a twelve month high of $5.65. The stock has a market cap of $16.04 million, a P/E ratio of -0.33 and a beta of 1.01.
Institutional Investors Weigh In On Palatin Technologies
A hedge fund recently bought a new stake in Palatin Technologies stock. XTX Topco Ltd purchased a new position in shares of Palatin Technologies, Inc. (NYSEAMERICAN:PTN – Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 14,631 shares of the biopharmaceutical company’s stock, valued at approximately $29,000. XTX Topco Ltd owned about 0.08% of Palatin Technologies at the end of the most recent reporting period. Hedge funds and other institutional investors own 11.50% of the company’s stock.
Wall Street Analyst Weigh In
Check Out Our Latest Stock Report on Palatin Technologies
Palatin Technologies Company Profile
Palatin Technologies, Inc, a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder.
See Also
- Five stocks we like better than Palatin Technologies
- What is Forex and How Does it Work?
- Visa and Mastercard: Top Payment Stocks to Watch After Rate Cuts
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- When Is the Best Time to Invest in Mutual Funds?
- Investing In Automotive Stocks
- Is NVIDIA Stock in a Correction or Consolidation?
Receive News & Ratings for Palatin Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palatin Technologies and related companies with MarketBeat.com's FREE daily email newsletter.